实现诱导耐受以预防急性移植物抗宿主病。
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease.
机构信息
Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
出版信息
Front Immunol. 2019 Mar 6;10:309. doi: 10.3389/fimmu.2019.00309. eCollection 2019.
Abstract
Acute graft-vs.-host disease (GVHD) limits the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT), a main therapy to treat various hematological disorders. Despite rapid progress in understanding GVHD pathogenesis, broad immunosuppressive agents are most often used to prevent and remain the first line of therapy to treat GVHD. Strategies enhancing immune tolerance in allo-HSCT would permit reductions in immunosuppressant use and their associated undesirable side effects. In this review, we discuss the mechanisms responsible for GVHD and advancement in strategies to achieve immune balance and tolerance thereby avoiding GVHD and its complications.
摘要
急性移植物抗宿主病（GVHD）限制了异基因造血干细胞移植（allo-HSCT）的疗效，allo-HSCT 是治疗各种血液系统疾病的主要方法。尽管人们对 GVHD 发病机制的理解取得了快速进展，但广泛使用免疫抑制剂来预防和仍然是治疗 GVHD 的一线疗法。增强 allo-HSCT 中免疫耐受的策略可以减少免疫抑制剂的使用及其相关的不良副作用。在这篇综述中，我们讨论了导致 GVHD 的机制以及实现免疫平衡和耐受的策略的进展，从而避免 GVHD 及其并发症。
相似文献
1
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease.实现诱导耐受以预防急性移植物抗宿主病。
Front Immunol. 2019 Mar 6;10:309. doi: 10.3389/fimmu.2019.00309. eCollection 2019.
2
[Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation].[细胞因子诱导的异基因造血干细胞移植免疫耐受]
Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Apr 18;41(2):208-11.
3
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.造血干细胞移植操作作为一种免疫治疗机制。
Int Immunopharmacol. 2003 Aug;3(8):1121-43. doi: 10.1016/S1567-5769(03)00014-6.
4
Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.在半相合造血干细胞移植到 F1 小鼠中，诱导来自两个不同亲鼠品系的耐受可预防移植物抗宿主病。
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1035-41. doi: 10.1016/j.bbrc.2014.03.055. Epub 2014 Mar 21.
5
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.在异基因移植前后暴露于检查点抑制剂会有严重的移植物抗宿主病风险。
Biol Blood Marrow Transplant. 2019 Jan;25(1):94-99. doi: 10.1016/j.bbmt.2018.08.028. Epub 2018 Sep 6.
6
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.供体T细胞上PD-1和CTLA-4的上调不足以预防异基因造血干细胞移植受者的移植物抗宿主病。
PLoS One. 2017 Sep 27;12(9):e0184254. doi: 10.1371/journal.pone.0184254. eCollection 2017.
7
Acute graft-vs-host disease: pathobiology and management.急性移植物抗宿主病：病理生物学与管理
Exp Hematol. 2001 Mar;29(3):259-77. doi: 10.1016/s0301-472x(00)00677-9.
8
A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.比林厄姆原则的修订：淋巴细胞迁移在急性移植物抗宿主病中的核心作用
Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):2-8. doi: 10.1016/j.bbmt.2005.09.015.
9
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.人类白细胞抗原-G 的免疫调节功能及其在异基因造血干细胞移植后移植物抗宿主病中的作用。
Ann Hematol. 2021 Jun;100(6):1391-1400. doi: 10.1007/s00277-021-04486-z. Epub 2021 Mar 11.
10
Early myeloid-derived suppressor cells (HLA-DR/CD33CD16) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT.早期髓系来源的抑制细胞（HLA-DR/CD33CD16）经粒细胞集落刺激因子扩增可预防人源化小鼠的急性移植物抗宿主病（GVHD），并可能降低 allo-HSCT 后患者的 GVHD 发生率。
J Hematol Oncol. 2019 Mar 18;12(1):31. doi: 10.1186/s13045-019-0710-0.
引用本文的文献
1
The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy.移植物抗白血病效应：供者淋巴细胞输注和细胞治疗。
Front Immunol. 2024 Mar 15;15:1328858. doi: 10.3389/fimmu.2024.1328858. eCollection 2024.
2
Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease.外多糖处理的树突状细胞可有效改善急性移植物抗宿主病。
Transplant Cell Ther. 2024 Jan;30(1):79.e1-79.e10. doi: 10.1016/j.jtct.2023.10.023. Epub 2023 Nov 2.
3
Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity.供体 T 细胞 STAT3 缺陷使组织 PD-L1 依赖性预防移植物抗宿主病，同时保留移植物抗白血病活性。
J Clin Invest. 2023 Aug 1;133(15):e165723. doi: 10.1172/JCI165723.
4
After Bone Marrow Transplantation, the Cell-Intrinsic Th2 Pathway Promotes Recipient T Lymphocyte Survival and Regulates Graft-versus-Host Disease.骨髓移植后，细胞内源性 Th2 途径促进受者 T 淋巴细胞存活并调节移植物抗宿主病。
Immunohorizons. 2023 Jun 1;7(6):442-455. doi: 10.4049/immunohorizons.2300021.
5
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities.异基因干细胞移植治疗急性髓系白血病：障碍与机遇概述
World J Clin Cases. 2023 Jan 16;11(2):268-291. doi: 10.12998/wjcc.v11.i2.268.
6
Analysis of factors associated with hematopoietic stem-cell retransplantation: a case-control study.与造血干细胞再移植相关因素的分析：一项病例对照研究。
Rev Lat Am Enfermagem. 2022;30:e3569. doi: 10.1590/1518-8345.5794.3569.
7
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges.调节性 T 细胞治疗移植物抗宿主病：进展与挑战。
Int J Mol Sci. 2021 Sep 7;22(18):9676. doi: 10.3390/ijms22189676.
8
Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells.人羊膜间充质干细胞通过调节调节性T细胞和效应性T细胞的平衡来抑制急性移植物抗宿主病。
J Inflamm Res. 2021 Aug 16;14:3985-3999. doi: 10.2147/JIR.S323054. eCollection 2021.
9
GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.GVHD 的发病机制、预防和治疗：来自人源化小鼠移植模型的经验教训。
Front Immunol. 2021 Jul 29;12:723544. doi: 10.3389/fimmu.2021.723544. eCollection 2021.
10
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD.自然杀伤 T 细胞的激活增强了调节性 T 细胞疗法抑制小鼠移植物抗宿主病的功能。
Blood Adv. 2021 Jun 8;5(11):2528-2538. doi: 10.1182/bloodadvances.2020003272.
本文引用的文献
1
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells.移植物抗宿主病而非移植物抗白血病免疫由 GM-CSF 许可的髓系细胞介导。
Sci Transl Med. 2018 Nov 28;10(469). doi: 10.1126/scitranslmed.aat8410.
2
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.延长 CCR5 阻断预防移植物抗宿主病可改善降低强度无关供者造血细胞移植的结局：一项 II 期临床试验。
Biol Blood Marrow Transplant. 2019 Mar;25(3):515-521. doi: 10.1016/j.bbmt.2018.09.034. Epub 2018 Oct 10.
3
T cells-the next frontier of cell therapy.T细胞——细胞疗法的下一个前沿领域。
Science. 2018 Oct 12;362(6411):154-155. doi: 10.1126/science.aau2688.
4
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.通过自体粪便微生物群移植重建抗生素治疗患者的肠道微生物群。
Sci Transl Med. 2018 Sep 26;10(460). doi: 10.1126/scitranslmed.aap9489.
5
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.肠道微生物群衍生的吲哚通过 I 型干扰素信号通路发挥作用，从而限制移植物抗宿主病。
Blood. 2018 Dec 6;132(23):2506-2519. doi: 10.1182/blood-2018-03-838193. Epub 2018 Sep 26.
6
Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease.靶向 JAK2 稳定 Foxp3 增强 CD8 诱导的调节性 T 细胞在预防移植物抗宿主病中的疗效。
J Immunol. 2018 Nov 1;201(9):2812-2823. doi: 10.4049/jimmunol.1800793. Epub 2018 Sep 21.
7
Microbial metabolite sensor GPR43 controls severity of experimental GVHD.微生物代谢物传感器 GPR43 控制实验性移植物抗宿主病的严重程度。
Nat Commun. 2018 Sep 10;9(1):3674. doi: 10.1038/s41467-018-06048-w.
8
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates.CD28 阻断控制 T 细胞激活，从而预防灵长类动物的移植物抗宿主病。
J Clin Invest. 2018 Aug 31;128(9):3991-4007. doi: 10.1172/JCI98793. Epub 2018 Aug 13.
9
Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.依替莫司对调节性和记忆性 T 细胞的作用不依赖于 Cpt1a 介导的脂肪酸氧化。
Cell Metab. 2018 Sep 4;28(3):504-515.e7. doi: 10.1016/j.cmet.2018.06.002. Epub 2018 Jun 28.
10
Mesenchymal Stromal Cells Stimulate the Proliferation and IL-22 Production of Group 3 Innate Lymphoid Cells.间质基质细胞刺激第三组固有淋巴细胞的增殖和白细胞介素-22 的产生。
J Immunol. 2018 Aug 15;201(4):1165-1173. doi: 10.4049/jimmunol.1700901. Epub 2018 Jul 6.
Zotero 插件